Cargando…
P545: VENETOCLAX (VEN) COMBINED WITH FLAG-IDA IS AN EFFECTIVE REGIMEN FOR PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428945/ http://dx.doi.org/10.1097/01.HS9.0000969088.50486.31 |
_version_ | 1785090592549634048 |
---|---|
author | Burkart, Madelyn Khan, Talha Dinner, Shira Frankfurt, Olga Altman, Jessica Abaza, Yasmin |
author_facet | Burkart, Madelyn Khan, Talha Dinner, Shira Frankfurt, Olga Altman, Jessica Abaza, Yasmin |
author_sort | Burkart, Madelyn |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10428945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104289452023-08-17 P545: VENETOCLAX (VEN) COMBINED WITH FLAG-IDA IS AN EFFECTIVE REGIMEN FOR PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) Burkart, Madelyn Khan, Talha Dinner, Shira Frankfurt, Olga Altman, Jessica Abaza, Yasmin Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428945/ http://dx.doi.org/10.1097/01.HS9.0000969088.50486.31 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Burkart, Madelyn Khan, Talha Dinner, Shira Frankfurt, Olga Altman, Jessica Abaza, Yasmin P545: VENETOCLAX (VEN) COMBINED WITH FLAG-IDA IS AN EFFECTIVE REGIMEN FOR PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) |
title | P545: VENETOCLAX (VEN) COMBINED WITH FLAG-IDA IS AN EFFECTIVE REGIMEN FOR PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) |
title_full | P545: VENETOCLAX (VEN) COMBINED WITH FLAG-IDA IS AN EFFECTIVE REGIMEN FOR PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) |
title_fullStr | P545: VENETOCLAX (VEN) COMBINED WITH FLAG-IDA IS AN EFFECTIVE REGIMEN FOR PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) |
title_full_unstemmed | P545: VENETOCLAX (VEN) COMBINED WITH FLAG-IDA IS AN EFFECTIVE REGIMEN FOR PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) |
title_short | P545: VENETOCLAX (VEN) COMBINED WITH FLAG-IDA IS AN EFFECTIVE REGIMEN FOR PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) |
title_sort | p545: venetoclax (ven) combined with flag-ida is an effective regimen for patients (pts) with newly diagnosed (nd) and relapsed/refractory (r/r) acute myeloid leukemia (aml) |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428945/ http://dx.doi.org/10.1097/01.HS9.0000969088.50486.31 |
work_keys_str_mv | AT burkartmadelyn p545venetoclaxvencombinedwithflagidaisaneffectiveregimenforpatientsptswithnewlydiagnosedndandrelapsedrefractoryrracutemyeloidleukemiaaml AT khantalha p545venetoclaxvencombinedwithflagidaisaneffectiveregimenforpatientsptswithnewlydiagnosedndandrelapsedrefractoryrracutemyeloidleukemiaaml AT dinnershira p545venetoclaxvencombinedwithflagidaisaneffectiveregimenforpatientsptswithnewlydiagnosedndandrelapsedrefractoryrracutemyeloidleukemiaaml AT frankfurtolga p545venetoclaxvencombinedwithflagidaisaneffectiveregimenforpatientsptswithnewlydiagnosedndandrelapsedrefractoryrracutemyeloidleukemiaaml AT altmanjessica p545venetoclaxvencombinedwithflagidaisaneffectiveregimenforpatientsptswithnewlydiagnosedndandrelapsedrefractoryrracutemyeloidleukemiaaml AT abazayasmin p545venetoclaxvencombinedwithflagidaisaneffectiveregimenforpatientsptswithnewlydiagnosedndandrelapsedrefractoryrracutemyeloidleukemiaaml |